Bristol-Myers Squibb has acquired iPierian, a privately held biotechnology company focused on the discovery and development of new treatments for Tauopathies, a class of neurodegenerative diseases associated with the pathological aggregation of Tau protein in the human brain … more

— UPCOMING EVENTS —

5/12 5:00 pm – 6:30 pm in New Haven

BioScienceClubhouseCT presents ‘SystaMedic: A Novel Cause-Effect Analysis Platform for Predicting Probability of R&D Program Success’  … more

5/14 9:00 am – 4:00 pm in New Haven

Diabetes Symposium: “Innovative Approaches to Diabetes Research and Therapies”  … more